Pharma Funds for Long-term Investors
Ninad Ramdasi / 28 Dec 2023/ Categories: DSIJ_Magazine_Web, DSIJMagazine_App, Letters to Editor, MF - Letter to Editor, Mutual Fund
Your extensive coverage regarding pharma funds was insightful.
Your extensive coverage regarding pharma funds was insightful. But, are pharmaceutical funds a good bet for long-term investors in India? - Madan Jadhav
[EasyDNNnews:PaidContentStart]
Editor Responds : Thank you for writing. Investing in pharmaceutical funds for long-term investors in India presents both opportunities and challenges. The sector is considered defensive, showcasing stability even in economic downturns due to the essential nature of healthcare. India's significant presence in the global pharmaceutical market, with a focus on generic drugs, and the outsourcing of drug manufacturing contribute to the sector's growth potential. However, investors need to be mindful of certain risks associated with the pharmaceutical sector. Regulatory risks, both domestic and international, can impact the industry's dynamics, leading to sudden changes in the operating environment. Continuous monitoring of regulatory changes, global pharmaceutical trends, and the financial health of the companies in these funds is advisable for a well-informed long-term investment strategy.
[EasyDNNnews:PaidContentEnd] [EasyDNNnews:UnPaidContentStart]
To read the entire article, you must be a DSIJ magazine subscriber.
Current print subscribers click here to login
Subscribe now to get DSIJ All Access
[EasyDNNnews:UnPaidContentEnd]